Open AccessHigh expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma
Author(s) -
Zhijian Xu,
Yidong Liu,
Yuanfeng Yang,
Jieti Wang,
Guodong Zhang,
Zheng Liu,
Hangcheng Fu,
Zewei Wang,
Haiou Liu
Publication year - 2016
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.13692
Subject(s) - clear cell renal cell carcinoma , medicine , renal cell carcinoma , oncology , nomogram , clear cell carcinoma , carcinoma , gynecology
Mucin13 (MUC13) is a transmembrane glycoprotein that is aberrantly expressed in ovarian and gastro-intestinal tumors, but its role in renal cell carcinoma remains elusive. The purpose of this study is to evaluate the prognostic value of MUC13 expression in patients with non-metastatic clear cell renal cell carcinoma (ccRCC) after surgical resection.